ANIKNasdaq United States
Market cap
$286.663 M
$21.42 +6.25%
Close of 7 Aug 2026
Revenue
$112.8M
#2478 by revenue
Earnings
-$11.0M
Loss-making
Shares outstanding
13,382,966
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Anika Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.